DXd
1 product
2 abstracts
Abstract
Evaluating antitumor activity and response determinants to trastuzumab deruxtecan in pediatric solid tumors.Org: Memorial Sloan Kettering Cancer Center,
Abstract
HER2 expression-independent antitumor effect of trastuzumab deruxtecan (T-DXd) on pediatric solid tumors.Org: Division of Cancer Immunodiagnostics, Children's Cancer Center, National Center for Child Health and Development,
Product
Dxd